Viewing nowHwanin Donepezil Tablet 5mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 5.215mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

MFDS item code 200802325 · Notified 2008.02.29 · Insurance code 657201240
Treatment of symptoms of Alzheimer-type dementia
This medicine is used for the treatment of symptoms of Alzheimer's-type dementia. It helps alleviate symptoms such as memory impairment and cognitive decline, assisting the patient in daily activities and improving quality of life. It is expected to slow disease progression or prevent worsening of symptoms. Therefore, it is actively utilized to improve symptoms in patients with Alzheimer's-type dementia.
○ Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose increase, administer a dose of 5 mg for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg per day, administer with caution for gastrointestinal adverse reactions. If this medicine is discontinued, its effect gradually diminishes; no rebound effect occurs with abrupt discontinuation. ○ Female patients aged 85 years or older with low body weight: Careful monitoring is required because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg per day.
○ Children: There is no experience with use in children.
This medication contains Donepezil Hydrochloride Hydrate as its active ingredient, used to alleviate Alzheimer's-type dementia symptoms. First, it should not be used by individuals who are allergic to this drug or similar components, women who are pregnant or may become pregnant, and women who are nursing. Patients with heart disease or conduction disorders need to be cautious when using this drug, as there may be a risk of bradycardia or arrhythmias. Those taking non-steroidal anti-inflammatory drugs or with a history of peptic ulcers should be careful, as this medication may stimulate gastric acid secretion and gastrointestinal motility, worsening ulcer symptoms. Patients with asthma or obstructive pulmonary disease should use this drug with caution, as it may worsen symptoms due to bronchoconstriction and increased mucus secretion. In cases of extrapyramidal disorders like Parkinson's disease, caution is necessary as this drug may exacerbate symptoms. Serious side effects such as fainting, heart problems, gastrointestinal bleeding, liver function abnormalities, cerebral hemorrhage, seizures, movement disorders, and severe muscle cramps may occur during the treatment; thus, immediate consultation with a physician is required if symptoms appear. Various side effects have also been reported, including nausea, vomiting, diarrhea, dizziness, insomnia, hallucinations, depression, myalgia, and fatigue; any abnormal symptoms during treatment should be reported to healthcare professionals. This medication can affect the heart, so patients with heart disease or electrolyte imbalances may require regular electrocardiogram tests. Caution should be exercised regarding driving or operating machinery, especially during the initial stages of treatment or when changing dosages. This drug may interact with other medications; therefore, consultation with a physician or pharmacist is recommended, especially if taking drugs related to CYP3A4 or CYP2D6. Women who are pregnant or nursing should avoid using this drug, and if necessary, breastfeeding should be discontinued. Safety in children has not been established, so it should not be used in pediatric patients. In cases of overdose, symptoms such as nausea, vomiting, bradycardia, and respiratory depression may occur, and immediate emergency treatment is required. This medication should be kept out of the reach of children and should not be transferred to other containers for safety purposes.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container that is well-ventilated, ideally maintaining a temperature between 1 and 30 degrees Celsius at room temperature. Storing it this way will help maintain the effectiveness of the medication.
White round film-coated tablet
For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle, For export - 30 tablets/PTP [(10 tablets/PTP×3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 5.215mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.